Increased risk of hospitalization and death with Parkinson’s drugAugust 19, 2021Parkinson's DiseaseMovement Disorders
Dance training ‘drastically’ reduces Parkinson’s progression, eases symptomsJuly 14, 2021Parkinson's Disease
Excessive drooling is a sign of greater dysfunction in patients with Parkinson’s diseaseJune 25, 2021Parkinson's DiseaseMovement Disorders
Neurodegeneration complicates psychiatric care for Parkinson’s patientsJune 21, 2021Movement DisordersParkinson's Disease
Photobiomodulation: Evaluation in a wide range of medical specialties underwayJune 16, 2021PainAlzheimer's & CognitionParkinson's DiseaseMixed Topics
FDA clears next-generation DBS system for movement disordersJune 8, 2021Movement DisordersParkinson's Disease
Deep brain stimulation is effective over the long haulJune 4, 2021Parkinson's DiseaseMovement Disorders
Psychosis, depression tied to neurodegeneration in Parkinson’sMay 24, 2021Movement DisordersParkinson's Disease
Basal ganglia microcircuits offer clues to Parkinson’s symptomsApril 30, 2021Parkinson's DiseaseNeuromuscular Disorders
Long-term benefit for DBS in treating Parkinson’s disease motor symptomsApril 26, 2021Parkinson's DiseaseMovement Disorders
Nondopamine antipsychotic shows clinical signal in Parkinson’s disease psychosisApril 22, 2021Parkinson's Disease
Can exercise prevent cognitive decline in patients with early Parkinson’s disease?April 8, 2021Parkinson's DiseaseMovement Disorders
